Cadrenal Therapeutics
CVKD
#9801
Rank
S$40.89 M
Marketcap
$21.76
Share price
-5.66%
Change (1 day)
76.91%
Change (1 year)

EPS for Cadrenal Therapeutics (CVKD)

EPS in 2024 (TTM): -$9.25

According to Cadrenal Therapeutics's latest financial reports the company's current EPS (TTM) is -$9.34. In 2023 the company made an earnings per share (EPS) of -$12.50.

EPS history for Cadrenal Therapeutics from 2023 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-$9.25-26.02%
2023-$12.50